
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
8/18/2025
0:00
29:55
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
More episodes from "Annals On Call Podcast"
Don't miss an episode of “Annals On Call Podcast” and subscribe to it in the GetPodcast app.